Boston Scientific Corp. Stock Slides 5.1%, Underperforms Peers
Dow Jones2026/08/20 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Boston Scientific Corp. slid 5.1% to $49.37 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.9% to 7,641.16 and Dow Jones Industrial Average falling 1.3% to 52,759.21.
Boston Scientific Corp. closed 54.9% short of its 52-week high of $109.50, which the company reached on September 9th.
The stock underperformed when compared to some of its peers, as Abbott Laboratories fell 0.3% to $114.14, Medtronic PLC fell 1.9% to $92.30, and Stryker Corp. fell 3.61% to $327.70.
Trading volume totaled 20.4 million, compared to the 50-day average of 19.6 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 20, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Atmos Energy forecasts 6%-8% annual EPS, dividend growth through fiscal 2030
Dark Defender: XRP Wave 3 Is On a Ballistic Missile Ramp
ISS targets 2026-28 organic growth above 5% annually, 2028 operating margin 5.5%-6%
ISS targets over 5% annual organic growth through 2028 under new mid-term plan